Spotlight on Shivani Srivastava
Shivani Srivastava, Immunologist
Dr. Shivani Srivastava grew up in an academic family. She remembers spirited debates between her grandfather, uncles, and father a mix of math professors and engineers by training.
“Something would be bothering them, a question would keep them up at night and chew at them. [I remember them] discussing it and arguing about it at the dining table,” she said. “And then when they figured something out together, they’d be so satisfied.”
Srivastava had always been interested in human disease, but didn’t expect to forge a career trying to overcome it. Initially, like her father and grandfather, she was more attracted to math and chemistry than biology.
March 10, 2021, by NCI Staff
The coronavirus pandemic initially led to sharp decreases in the use of cancer screening tests, such as low-dose CT scans for lung cancer.
Credit: Used with permission from the University of Cincinnati
In January, First Lady Dr. Jill Biden visited a community health clinic near the White House to learn about the impact of COVID-19 on access to preventive care, including cancer screening.
At Whitman-Walker Health, Dr. Biden learned, the coronavirus pandemic initially led to sharp decreases in the use of recommended cancer screening tests, which could mean that some early cancers may have gone undetected.